1. Home
  2. PBLS vs VCYT Comparison

PBLS vs VCYT Comparison

Compare PBLS & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$29.99

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Logo Veracyte Inc.

VCYT

Veracyte Inc.

HOLD

Current Price

$59.16

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBLS
VCYT
Founded
N/A
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.1B
IPO Year
2026
2013

Fundamental Metrics

Financial Performance
Metric
PBLS
VCYT
Price
$29.99
$59.16
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$44.00
AVG Volume (30 Days)
545.1K
1.3M
Earning Date
N/A
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
164.52
EPS
N/A
0.35
Revenue
N/A
N/A
Revenue This Year
N/A
$13.76
Revenue Next Year
N/A
$12.35
P/E Ratio
N/A
$161.57
Revenue Growth
N/A
N/A
52 Week Low
$25.56
$22.61
52 Week High
$33.65
$60.91

Technical Indicators

Market Signals
Indicator
PBLS
VCYT
Relative Strength Index (RSI) 58.14 62.45
Support Level $26.96 $40.27
Resistance Level $30.19 $60.91
Average True Range (ATR) 2.49 2.80
MACD 0.18 -0.49
Stochastic Oscillator 54.84 73.72

Price Performance

Historical Comparison
PBLS
VCYT

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Share on Social Networks: